Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study

References

• HemmettLHolmesJBarnesMRussellNWhat drives quality of life in multiple sclerosis?QJM2004971067167615367738
   PubMed Web of Science ®Google Scholar
• KelleherKJSpenceWSolomonidisSApatsidisDAmbulatory rehabilitation in multiple sclerosisDisabil Rehabil200931201625163219479529
   PubMed Web of Science ®Google Scholar
• ColemanCISidovarMFRobertsMSKohnCImpact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosisPLoS One201381e5475623355896
   PubMed Web of Science ®Google Scholar
• GoodmanADBrownTREdwardsKRA phase 3 trial of extended release oral dalfampridine in multiple sclerosisAnn Neurol201068449450220976768
   PubMed Web of Science ®Google Scholar
• GoodmanADBrownTRKruppLBSustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trialLancet2009373966573273819249634
   PubMed Web of Science ®Google Scholar
• CameronMHFitzpatrickMOversSMurchisonCManningJWhithamRDalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort studyMult Scler201420673373824099749
   PubMed Web of Science ®Google Scholar
• Latimer-CheungAEPiluttiLAHicksALEffects of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults with multiple sclerosis: a systematic review to inform guideline developmentArch Phys Med Rehabil20139491800.e31828.e323669008
   PubMed Web of Science ®Google Scholar
• MotlRWPiluttiLAThe benefits of exercise training in multiple sclerosisNat Rev Neurol20128948749722825702
   PubMed Web of Science ®Google Scholar
• RatchfordJNShoreWHammondERA pilot study of functional electrical stimulation cycling in progressive multiple sclerosisNeuro-Rehabilitation201027212112820871141
   PubMed Web of Science ®Google Scholar
• SteinRBEveraertDGThompsonAKLong-term therapeutic and orthotic effects of a foot drop stimulator on walking performance in progressive and nonprogressive neurological disordersNeurorehabil Neural Repair201024215216719846759
   PubMed Web of Science ®Google Scholar
• BarrettCLMannGETaylorPNStrikePA randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosisMult Scler200915449350419282417
   PubMed Web of Science ®Google Scholar
• MillerLMcFadyenALordACFunctional electrical stimulation for foot drop in multiple sclerosis: a systematic review and meta-analysis of the impact on gait speedArch Phys Med Rehabil Epub2017111
   Web of Science ®Google Scholar
• ArtemiadisAKVervainiotiAAAlexopoulosECRombosAAnagnostouliMCDarviriCStress management and multiple sclerosis: a randomized controlled trialArch Clin Neuropsychol201227440641622491729
   PubMed Web of Science ®Google Scholar
• MohrDCLoveraJBrownTA randomized trial of stress management for the prevention of new brain lesions in MSNeurology201279541241922786596
   PubMed Web of Science ®Google Scholar
• ReeseDShivapourETWahlsTLDudley-JavoroskiSDShieldsRNeuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case reportCases J20092760119918474
   PubMedGoogle Scholar
• WahlsTLReeseDKaplanDDarlingWGRehabilitation with neuromuscular electrical stimulation leads to functional gains in ambulation in patients with secondary progressive and primary progressive multiple sclerosis: a case series reportJ Altern Complement Med201016121343134921138391
   PubMed Web of Science ®Google Scholar
• CohenJACutterGRFischerJSBenefit of interferon beta-1a on MSFC progression in secondary progressive MSNeurology200259567968712221157
   PubMed Web of Science ®Google Scholar
• VermerschPBenrabahRSchmidtNMasitinib treatment in patients with progressive multiple sclerosis: a randomized pilot studyBMC Neurol2012123622691628
   PubMed Web of Science ®Google Scholar
• BishtBDarlingWGGrossmannREA multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigueJ Altern Complement Med201420534735524476345
   PubMed Web of Science ®Google Scholar
• BishtBDarlingWGShivapourETMultimodal intervention improves fatigue and quality of life of subjects with progressive multiple sclerosis: a pilot studyDegenerative Neurological Neuromuscular Disease2015201551935
   Google Scholar
• CutlipRGMancinelliCHuberFDiPasqualeJEvaluation of an instrumented walkway for measurement of the kinematic parameters of gaitGait Posture200012213413810998610
   PubMed Web of Science ®Google Scholar
• KruppLBLaRoccaNGMuir-NashJSteinbergADThe fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosusArch Neurol19894610112111232803071
   PubMed Web of Science ®Google Scholar
• KapoorRFurbyJHaytonTLamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trialLancet Neurol20109768168820621711
   PubMed Web of Science ®Google Scholar
• KhaleeliZSastre-GarrigaJCiccarelliOMillerDHThompsonAJMagnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosisJ Neurol Neurosurg Psychiatry200778101076108217287235
   PubMed Web of Science ®Google Scholar
• NilsagardYLundholmCGunnarssonLGDcnisonEClinical relevance using timed walk tests and ‘timed up and go’ testing in persons with multiple sclerosisPhysiother Res Int200712210511417536648
   PubMedGoogle Scholar
• HobartJBlightARGoodmanALynnFPutzkiNTimed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MSNeurology201380161509151723535489
   PubMed Web of Science ®Google Scholar
• LearmonthYCPaulLMcFadyenAKMattisonPMillerLReliability and clinical significance of mobility and balance assessments in multiple sclerosisInt J Rehabil Res2012351697422315143
   PubMed Web of Science ®Google Scholar
• LaroccaNGImpact of walking impairment in multiple sclerosis: perspectives of patients and care partnersPatient20114318920121766914
   PubMedGoogle Scholar
• SalterARCutterGRTyryTMarrieRAVollmerTImpact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MSCurr Med Res Opin201026249350020014979
   PubMed Web of Science ®Google Scholar
• HuppertsRLyckeJShortCProlonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trialMult Scler201622221222125921050
   PubMed Web of Science ®Google Scholar
• HoffmannVSchimrigkSIslamovaSEfficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patientsJ Neurol Sci200321112818412767490
   PubMed Web of Science ®Google Scholar
• HoffmannVKuhnWSchimrigkSRepeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patientsEur J Neurol2006131727616420395
   PubMed Web of Science ®Google Scholar
• HellwigKSteinFJPrzuntekHMullerTEfficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptomsBMC Neurol2004411815530171
   PubMed Web of Science ®Google Scholar
• Abu-MugheisibMBeneckeRZettlUKRepeated intrathecal triamcinolone acetonide administration in progressive multiple sclerosis: a reviewMultSclerInt20112011219049
   Google Scholar